☆ 4.5 Meeting Abstract

Brigatinib vs crizotinib in ALK TKI-naive ALK plus NSCLC: final results from ALTA-1L

LUNG CANCER (2022)

Add to Collection

Journal

LUNG CANCER
Volume 165, Issue -, Pages S27-S28

Publisher

ELSEVIER IRELAND LTD

Keywords

-

Categories

Oncology Respiratory System

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.